Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Cefprozil Chewable Tablets

Approval Number

国药准字H20060575

Company广州白云山光华制药股份有限公司

Registration Date

June 12, 2020

Drug Information

Generic Name

头孢丙烯咀嚼片

Brand Name

白云山

Dosage Form

片剂

Strength

按C18H19N3O5S计0.25g

Drug Type

化学药品

Registration Date

June 12, 2020

Company Information

Applicant Company

Company Name广州白云山光华制药股份有限公司

Manufacturing Company

Company Name广州白云山光华制药股份有限公司

Company Address

广州市海珠区南石路1号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy